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In general, in toxicological risk assessment
ofenvironmental contaminants in humans
and mammals, there is little information
available on the bioavailability of toxic
compounds. Applying inadequate correc-
tions for incomplete absorption can lead to
considerable overestimation ofthe internal
dose. Recent investigations in cows on the
bioavailability of dioxins bound to fly ash
have clearly shown that the bioavailability
of the different dioxin congeners strongly
depends on the matrix to which the diox-
ins are bound (1). Mean bioavailability of
dioxins from fly ash in cows is about 1%,
which is considerably less than the 30%
bioavailability ofdioxin congeners from oil
(2).
A situation analogous to that for the
dioxins may hold true for metals. In some
parts of the Netherlands, bog ore-contain-
ing soils predominate, which have natural
arsenic levels that exceed, by a factor of 10,
existing Dutch standards for maximum
allowable levels for inorganic arsenic in
soil, currently set at 50 mg/kg dry weight.
In setting the tolerable intake ofarsenic in
humans, bioavailability from soil was
assumed to be equal to that from a solution
as used in toxicity studies. The main prob-
lems in setting the standards were that the
limit setters took into account neither the
form of arsenic nor route of exposure or
the toxicological effects of its different
forms (3). In a recent paper (4), adjusted,
toxicologically based soil clean-up criteria
have been proposed, taking into account
differences in species, bioavailability, etc.
Bioavailability of inorganic arsenic
from solutions was found to be more than
90% (5-9). However, as shown in Figure
1, arsenate (the most common form of
arsenic in soil) is specifically bound to bog
ore (10). This makes the assumption that
the bioavailability ofarsenic from bog ore-
containing soil is equal to that from solu-
tions questionable.
The aim of the present study was to
examine whether there is a scientific basis
for reconsidering the present practice of
risk assessment for arsenic in soil from resi-
dential areas. For this purpose, dogs were
used as an animal model because they are
relatively easy to administer large amounts
of soil. Furthermore, the rat is not a suit-
able animal model for studies on arsenic
because in this species, 50% ofthe arsenic
accumulates in the erythrocytes (11),
which is not the case in dog and man.
We collected soil from an area in
Doetinchem in the province ofGelderland,
the Netherlands. Samples were taken at 60
and 80 cm depth. Detailed information
about this area is available from earlier
investigations (12). Soil samples were
stored at40C until use.
For intravenous injection, we prepared
a solution with a final concentration of 2
mg As/ml in saline using As2O5 (Tritisol
lot no. 09014068, Merck, Darmstadt,
Germany).
The experiments were performed using
three male and three female beagles (DoBe)
from the cohort of the Unit Biotrans-
formation, Pharmacokinetics and Toxico-
kinetics, National Institute of Public
Health and Environmental Protection, the
Netherlands. These animals were kept
under conventional conditions. Their
weight was between 10 and 15 kg and their
age between 2 and 7 years. Individual data
are given in Table 1. The dogs received
200 g ofcommercially available food twice
daily. The experiment was performed
according to a two-way crossover design,
allowing each dog to be its own reference,
and excluding the time factor as a possible
cause ofdifferences in results.
The bioavailability of arsenic from soil
was related to an intravenous (IV) adminis-
tered dose of arsenic. The IV dose was 2
mg As, administered as As2O in saline via
the vena cephalica. For oral administration,
soil from 80 cm depth was used because
this sample was more homogeneous than
the sample from 60 cm. Each animal
received 20 g ofsoil mixed with 200 g of
food. Dose levels for arsenic in soil were
chosen based on data obtained in a pilot
experiment. The objective was to obtain
comparable plasma levels of arsenic after
both routes ofadministration.
Before each administration, the ani-
mals were fasted for 16 hr. Administration
always took place between 0900 and 1000
hr. At 1600 hr the day of administration
and on every nonadministration day at
0900 am and 1600 hr, the animals re-
ceived 200 g of food. During the experi-
ment, tap water was available ad libitum.
The dogs were individually housed in
metabolism cages, and during a 120-hr
period after administration, urine was
Figure 1. Schematic representation ofthe binding of arsenic to bog ore(lo).
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Table 1. Characteristics of the dogs used in the experiment to determine the bioavailability of arsenic
from soil
Session 1 Session 2
Name Gender Weight(kg) Route Dose (mg As) Weight(kg) Route Dose(mg As)
Xerxes M 10.9 PO 6.74 11.9 IV 2.00
Dombo M 14.1 IV 2.00 13.6 PO 6.67
Castor M 13.9 IV 2.00 13.9 PO 6.64
Plekky F 11.2 PO 7.01 11.6 IV 2.00
Anonymus F 11.3 IV 2.00 11.8 PO 7.35
Ursula F 11.6 PO 6.57 11.7 IV 2.00
Abbreviations: IV, intravenous; PO, oral.
caught in 24-hr fractions in glass bottles native step, and a blank determination to
containing 5 ml of 4 M nitric acid. Urine check for the reagents' purity. The detec-
samples were stored at -18 C until analysis. tion limit of the procedure was 1 pg/g.
We determined arsenic in soil using Arsenic measured in soil-5 was 97 pg/g,
atomic emission spectrometry with induc- being well within the 95% confidence
tively coupled plasma (ICP-AES). The interval of93.9 ± 7.5 pg/g. Recovery ofthe
apparatus used was a Perkin Elmer ICP standard addition experiments was 102 ± 6
6000 and instrumental settings were as rec- %, indicating that no matrix-induced sensi-
ommended by the manufacturer. The spec- tivity changes were present. Arsenic was not
tral line was the 189.042 line employing detected in the reagent blank.
background correction and nitrogen flush We determined levels of total arsenic in
for the spectrometer to reduce light absorp- urine, food, and the solution for IV injection
tion at this wavelength. using a procedure ofwet digestion ofarsenic
The soil samples (1-3 kg each) were to As(V), reduction to As(III), isolation and
hand-homogenized using a plastic spatula, complexation of arsine (AsH3) with silver
after which four subsamples of about 5 g diethyldithiocarbamate (AgDDTC), fol-
each were taken from each sample. The lowed by molecular absorption spectrometry
samples were processed as received, i.e., in (MAS). Absorption was measured at 526
wet condition. The subsamples were di- nm. Sample sizes were taken depending on
gested with aqua regia under reflux (13). In the expected arsenic content, resulting in
this procedure, 4 ml ofnitric acid, 65%, 12 amounts ofarsenic within the linear range of
ml ofhydrochloric acid, 37%, and 50 ml of the method (i.e. 0.5-20 pg per test solu-
distilled water were added to the sample, tion). The validity of this method has been
and the mixture was boiled for 2.5 hr. After demonstrated for several products and bio-
cooling down, we diluted the digests with logical materials, such as fruit (14). Further-
water to 100 ml. After decantation, the more, the arsenic content in several standard
digests were readyforanalysis. reference materials has been determined
Quality control included the digestion using this method (15). In the presentstudy,
of a standard reference material (soil-5 of the levels of arsenic in eight urine samples
the IAEA Vienna), application ofstandard were determined in duplicate from separate
addition to the digests to check for matrix- test portions and in two samples by dupli-
induced sensitivity changes in the determi- cate measurement in the same digest.
Table 2. Excretion of arsenic in urine (percent ofdose) after intravenous and oral administration
Urine fraction (hr)
Name 0-24 24-48 48-72 72-96 96-120 Total
Intravenous
Xerxes 79 8.5 1.5 2 1.5 92.5
Dombo 88 4 3.5 1 1 97.5
Castor 78.5 8 3 1 1 91.5
Plekky 90.5 5.5 2.5 1.5 1.5 101.5
Anonymus 41 10 3.5 1 1.5 57
Ursula 74.5 7 2 1 1.5 86
Mean 75 7.2 2.67 1.25 1.33 88
SD 18 2.2 0.82 0.42 0.26 16
Oral (soil)
Xerxes 3.41 2.23 0.59 0.15 0.15 6.53
Dombo 6 1.5 0.6 0.45 0.45 9.00
Castor 3.31 1.66 0.75 0.6 0.3 6.52
Plekky 4.85 0.43 0.14 0.14 0.14 5.70
Anonymus 4.35 1.09 0.28 0.28 0.28 6.28
Ursula 3.96 2.13 2.13 0.15 0.15 8.52
Mean 4.2 1.5 0.75 0.30 0.25 7.0
SD 1.0 0.67 0.71 0.19 0.13 1.5
Total content of arsenic in food was
determined in samples from the two
batches used during the experiment.
Results were 0.063 and 0.059 mg/kg,
respectively. The arsenic content in the
solution for IV injection was 2.0 mg/ml.
Comparison of the excretion half-lives
after IV and oral administration ofarsenic
was performed using the Student's t-test
on log-transformed values.
From the results of the determination
ofarsenic in soil, it was obvious that at 60
cm depth, arsenic was less homogeneously
distributed (concentration 323 ± 74 pg/g
wet weight) than at 80 cm depth (339 ±
19 pg/g wet weight). Therefore, the latter
was used in the animal experiments. From
previous reports, we knew that arsenate
was the predominant species in soil from
this area (12,13).
In Table 2, the data for the excretion
of arsenic in urine after IV and oral
administration are presented. After IV
administration, most ofthe dose appeared
to be excreted within 24 hr. Within 120
hr after administration, almost the entire
dose was recovered in urine of five out of
six dogs. Only one dog, Anonymus, had a
low urinary recovery of 57% within 120
hr.
After administration of arsenic con-
taining bog-ore mixed with food, no more
than 7.0 ± 1.5% ofthe dose was recovered
in urine within 120 hr.
Typical excretion curves after IV and
oral administration are shown in Figure 2.
After IV administration, two phases in the
excretion curve are observed. The first part
of the curve shows a half-life of 8.1 ± 3.7
hr, whereas the second part of the curve
shows a half-life of 28.4 ± 8.7 hr. After
oral administration of arsenic-containing
soil, only an excretion phase with a half-
life of 18.7 ± 5.2 hr was observed. The ter-
minal half-lives of excretion were not sig-
nificantly different between the routes of
administration (Table 3).
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Figure 2. Typical excretion curves of arsenic in
urine after administration of inorganic arsenic,
either as an intravenous injection (i.v; 2.0 mg)
ororally as a contaminant in soil(p.o.; 6.64mg).
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Bioavailability of arsenic from the
administered soil was calculated using the
equation:
A(0-120)po x DiV x100% = F
A(O-120)iv Dpo
where A(0 120)p, and A(0o120)iv are the
amounts ofarsenic excreted in urine with-
in 120 hr after oral and IV administration,
respectively. DPO and DA. are the oral and
IV dose, respectively.
Bioavailability ofarsenic from bog ore-
containing soil was 8.3 ± 2.0%. Individual
data are given in Table 3.
The study described here was per-
formed to determine the bioavailability of
arsenic from bog ore-containing soil. The
dog was used as an animal model for this
objective. This type ofstudy was triggered
by the discussion about whether to recon-
sider the present regulation for arsenic in
soil from domestic areas, since in some
areas, natural arsenic levels significantly
exceed existing standards (4). In general,
regulation is, among other things, based on
the assumption that the bioavailability of
contaminants from soil is the same as the
bioavailability from a solution or from
food. This assumption is questionable
because the matrix can significantly influ-
ence the bioavailability.
Based on literature data (5,16,1), the
studywas designed assuming that excretion
ofarsenic only takes place renally. This was
confirmed in our study after IV adminis-
tration ofarsenic. The values for the elimi-
nation half-life were comparable to those
Table 3. Excretion rate and bioavailability of inor-
ganic arsenic
t12(hr)
Name IV PO F(%)
Xerxes 33.9 15.5 7.1
Dombo 30.8 19.2 9.2
Castor 22.7 28.7 7.2
Plekky 37.8 14.3 5.6
Anonymus 13.7 17.2 11.0
Ursula 31.3 17.0 9.9
Mean 28.4 18.7 8.3
SD 8.7 5.2 2.0
t112,excretion half-life; F, bioavailability ofarsenic
based on urinary excretion.
reported in literature (11). Our data show
that only about 8% of arsenic from bog
ore-containing soil is absorbed from the
gastrointestinal tract and excreted into
urine. Thus, bioavailability ofarsenic from
soil is much lower than from a solution,
either containing As(III) or As(V) (5,8,9).
Seventy-three percent of orally adminis-
tered As203 in water was recovered in
urine of female monkeys (5). After inges-
tion of dissolved inorganic As(V) by two
volunteers, 64-69% ofthe dosewas excret-
ed into urine within 166 hr (9). However,
several factors, such as species tested and
dietary status, could modify the extent of
absorption.
Comparing data from the present study
with those from a study using a gastric
juice simulation test reveals that the simu-
lation test underestimated the release of
arsenic from bog ore-containing soil. In
the gastric simulation test, a release ofless
than 1% was found (12). The results
obtained from the present investigation on
the bioavailability of inorganic arsenic
from bog ore-containing soil in dogs stress
the need to reconsider the present practice
ofrisk assessment for arsenic in soil in resi-
dential areas.
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